Atypical antipsychotics are an option for treating serious psychosis of Alzheimer's disease, despite safety concerns and lack of evidence

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.11, 2007-11, pp. : 13-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atypical antipsychotics still being prescribed, despite warnings

By  

Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics still being prescribed, despite warnings

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 478, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cholinesterase inhibitors and atypical antipsychotics may help manage dementia and psychosis in Parkinson's disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 3, 2007-03 ,pp. : 7-10

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics "widely used off-label", despite warnings

By  

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics "widely used off-label", despite warnings

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite